Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
1
|
| pubmed:dateCreated |
1989-1-31
|
| pubmed:abstractText |
Six patients who developed urticaria, dyspnea, and anaphylactic shock due to topical application of chlorhexidine gluconate solution are described. Chlorhexidine gluconate was confirmed as the causative agent of type I hypersensitivity by intradermal, scratch, and epicutaneous tests. To prevent life-threatening adverse reactions, it seems important to use chlorhexidine gluconate on wound surfaces at a concentration of 0.05%, as recommended by the manufacturer; chlorhexidine gluconate may not be suitable for application to mucous membranes.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
AIM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Jan
|
| pubmed:issn |
0003-987X
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
125
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
50-2
|
| pubmed:dateRevised |
2008-3-17
|
| pubmed:meshHeading |
pubmed-meshheading:2910207-Adolescent,
pubmed-meshheading:2910207-Adult,
pubmed-meshheading:2910207-Anaphylaxis,
pubmed-meshheading:2910207-Child,
pubmed-meshheading:2910207-Chlorhexidine,
pubmed-meshheading:2910207-Drug Hypersensitivity,
pubmed-meshheading:2910207-Dyspnea,
pubmed-meshheading:2910207-Female,
pubmed-meshheading:2910207-Humans,
pubmed-meshheading:2910207-Hypersensitivity, Immediate,
pubmed-meshheading:2910207-Male,
pubmed-meshheading:2910207-Middle Aged,
pubmed-meshheading:2910207-Patch Tests,
pubmed-meshheading:2910207-Urticaria
|
| pubmed:year |
1989
|
| pubmed:articleTitle |
Anaphylactic symptoms due to chlorhexidine gluconate.
|
| pubmed:affiliation |
Department of Dermatology, Osaka University School of Medicine, Japan.
|
| pubmed:publicationType |
Journal Article,
Case Reports
|